Unilesional mycosis fungoides successfully treated with imiquimod [4]

European Journal of Dermatology

Volumn 16, Issue 4, 2006, Pages 446-

  Ardigò, Marco ^a   Cota, Carlo ^a   Berardesca, Enzo ^a  

^a SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD;

ADULT; ANAMNESIS; BLOOD ANALYSIS; CASE REPORT; CLINICAL FEATURE; DRUG EFFICACY; HUMAN; LETTER; MALE; MYCOSIS FUNGOIDES; POLYMERASE CHAIN REACTION; QUALITY OF LIFE; TREATMENT OUTCOME;

ADULT; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; HUMANS; MALE; MYCOSIS FUNGOIDES; REMISSION INDUCTION; SKIN NEOPLASMS;

EID: 33748327012     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (7)

1. Hodak E, Phenig E, Amichai B, Feinmesser M, Kuten A, Maron L, Sahar D, Bergman R, David M. Unilesional mycosis fungoides: a study of seven cases. Dermatology 2000; 201: 300-6.
2. Deeths MJ, Chapman JT, Dellavalle RP, Zeng C, Aeling JL. Treatment of patch and plaque stage mycosis fungoides with imiquimod 5% cream. J Am Acad Dermatol 2005; 52: 275-80.
3. Suchin KR, Junkins-Hopkins JM, Rook AH. Treatment of stage IA cutaneous T-Cell lymphoma with topical application of the immune response modifier imiquimod. Arch Dermatol 2002; 138: 1137-9.
4. Herbert WC. Imiquimod and the treatment of cutaneous T-cell proliferative diseases: at the threshold. Skinmed 2003; 2: 273-4.
5. Chong A, Loo WJ, Banney L, Grant JW, Norris PG. Imiquimod 5% cream in the treatment of mycosis fungoides-a pilot study. J Dermatolog Treat 2004; 15: 118-9.
6. Dummer R, Urosevic M, Kempf W, Kazakov D, Burg G. Imiquimod induces complete clearance of a PUVA-resistant plaque in mycosis fungoides. Dermatology 2003; 207: 116-8.
7. Sauder DN. Imiquimod: modes of action. Br J Dermatol 2003; 149 Suppl 66: 5-8.